₹515.55
−2.50%NSE close, 16 Nov 2026
−28.82%
Krsnaa Diagnostics is a small cap company, listed on NSE under the symbol KRSNAA. At ₹515.55 a share, the market values the whole company at ₹1,672 crore.
In FY26, it reported sales of ₹773 crore and a net profit of ₹101 crore, an operating margin of 27.4%. Over the last three years, sales grew 19.3% a year and net profit grew 14.0% a year.
The market values the company at 17.0 times its profit over the last twelve months and 1.61 times its book value; its return on equity is 9.4% and its borrowings are 0.57 times its equity.
Promoters hold 27.11% of the shares. Foreign institutions hold 3.84%, and domestic institutions, mutual funds among them, 14.50%.
Over the past year the share price has fallen 31.6%, and it is 38.5% below its 52-week high.
₹ crore. Consolidated figures.
Transcript
The Shifting of Corporate Office of Registrar And Share Transfer Agent of The Company w.e.f. 1st December, 2026
Link of Recording
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 158 | 166 | 170 | 186 | 175 | 186 | 193 | 206 | 181 | 193 | 236 | 271 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 121 | 123 | 128 | 137 | 129 | 133 | 142 | 147 | 135 | 138 | 178 | 200 |
| Operating profit | 37.4 | 43.7 | 42.7 | 49.4 | 45.1 | 53.0 | 51.4 | 59.2 | 46.4 | 54.9 | 58.0 | 71.1 |
| Operating margin | 23.6% | 26.3% | 25.1% | 26.5% | 25.8% | 28.5% | 26.6% | 28.7% | 25.6% | 28.5% | 24.6% | 26.2% |
| Other income | 4.1 | 4.3 | 7.3 | 4.6 | 9.2 | 4.4 | 4.0 | 4.2 | 3.8 | 31.5 | 7.2 | 6.2 |
| Interest | 4.1 | 7.3 | 5.3 | 6.4 | 6.1 | 6.8 | 6.3 | 8.2 | 7.8 | 12.1 | 14.8 | 15.5 |
| Depreciation | 21.2 | 18.1 | 21.5 | 22.2 | 22.7 | 22.0 | 21.6 | 23.6 | 22.7 | 22.6 | 28.0 | 29.1 |
| Profit before tax | 16.1 | 22.6 | 23.2 | 25.4 | 25.5 | 28.6 | 27.4 | 31.6 | 19.8 | 51.7 | 22.4 | 32.8 |
| Tax | 3.1 | 3.9 | 5.3 | 5.8 | 6.1 | 7.9 | 6.9 | 7.6 | 4.4 | 10.0 | 5.9 | 8.2 |
| Net profit | 13.0 | 18.7 | 17.9 | 19.6 | 19.4 | 20.7 | 20.5 | 24.0 | 15.3 | 41.7 | 16.6 | 24.6 |
| EPS (₹) | 4.09 | 5.80 | 5.55 | 6.07 | 6.01 | 6.40 | 6.35 | 7.38 | 4.72 | 12.86 | 5.10 | 7.64 |
₹ crore, financial years to March.
| Line | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 455 | 487 | 717 | 773 |
| Expenses | 324 | 365 | 527 | 561 |
| Operating profit | 131 | 122 | 190 | 212 |
| Operating margin | 28.9% | 25.1% | 26.5% | 27.4% |
| Other income | 14.9 | 19.4 | 25.5 | 43.4 |
| Interest | 18.5 | 7.7 | 24.7 | 34.4 |
| Depreciation | 41.4 | 53.8 | 88.3 | 90.5 |
| Profit before tax | 86.5 | 80.2 | 103 | 130 |
| Tax | 18.1 | 18.1 | 25.1 | 28.9 |
| Net profit | 68.4 | 62.1 | 77.6 | 101 |
| EPS (₹) | 22.89 | 20.64 | 24.04 | 31.30 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | 128 | 87.3 | 143 | 78.8 |
| From investing | −241 | −99.6 | −396 | −86.2 |
| From financing | 176 | 13.8 | 279 | 54.6 |
| Spent on fixed assets | −132 | −127 | −219 | −250 |
| Free cash flow | −3.8 | −39.3 | −76.2 | −171 |
Margins, returns, debt, tax and cash.
| Line | FY22 | FY23 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 15.0% | 12.8% | 10.8% | 13.1% |
| Operating margin | 28.9% | 25.1% | 26.5% | 27.4% |
| Return on equity | – | 8.4% | 8.8% | 10.3% |
| Return on capital employed | – | 11.4% | 11.7% | 10.9% |
| Return on assets | – | 6.8% | 6.1% | 5.6% |
| Debt to equity | – | 0.04 | 0.23 | 0.55 |
| Interest coverage | 5.70 | 11.40 | 5.20 | 4.80 |
| Debt to assets | – | 0.04 | 0.16 | 0.29 |
| Current ratio | – | 2.28 | 1.36 | 2.68 |
| Quick ratio | – | 2.02 | 1.26 | 2.59 |
| Cash ratio | – | 0.23 | 0.01 | 0.11 |
| Asset turnover | – | 0.54 | 0.56 | 0.42 |
| Fixed asset turnover | – | 1.04 | 1.07 | 1.19 |
| Inventory turnover | – | – | 5.70 | 6.70 |
| Receivables turnover | – | 6.70 | 2.60 | 2.60 |
| Gross margin | – | – | 76.4% | 76.8% |
| Cash from operations to profit | 188.0% | – | 113.0% | 141.0% |
| Effective tax rate | 20.9% | 22.6% | 24.4% | 22.2% |
Krsnaa Records Highest Ever Quarterly Revenue of Rs 2,710 Mn
The financial results for the period ended September 30, 2026.
Schedule of meet
Krsnaa Diagnostics Announces Strategic AI Collaboration with Global Radiology AI Innovator AZmed, Creating a Platform for Greater Reporting Efficiency and Scalable Growth
Allotment of 1621000 securities pursuant to Preferential Issue at its meeting held on October 13, 2026